healthy male volunteers
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy normal male subjects examined by health check using blood and brain MRI examination before PET scan
Exclusion criteria
Exclusion criteria: Healthy normal male subjects taking any drugs Healthy normal male subjects who became another volunteers of PET studies. Healthy normal male subjects with severe allergic diseases Healthy normal male subjects with family history of glaucoma and benign prostatic hypertrophy Healthy normal male subjects who can not take antihistamines and anticholinergic drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Histamine H1 receptor occupancy of desloratadine 5 mg and loratadine 10 mg at Tmax after single oral administration | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation between histamine H1 receptor occupancy and subjective sleepiness and plasma pharmakokinetics after single oral administration of desloratadine 5 mg and loratadine 10 mg. | — |
Countries
Japan
Contacts
Tohoku University, Cyclotron and Radioisotope Center Division of Cyclotron Nuclear Medicine